Search results
PROMOTED
Author(s):
Nicolas M Van Mieghem
,
Kendra J Grubb
,
David Hildick-Smith
,
et al
Start date:
Mar 26, 2024
Author(s):
Nils Perrin
,
Anita W Asgar
Added:
2 years ago
Author(s):
Florian Hecker
,
Mani Arsalan
,
Thomas Walther
Added:
3 years ago
Transcatheter aortic valve replacement (TAVR) has become the default treatment option for high-risk patients with aortic stenosis (AS) and, based on heart team discussion, an alternative to surgical aortic valve replacement (SAVR) in intermediate-risk patients.
TAVR has led to a paradigm shift in the basic therapeutic principle to treat AS: calcifications, in some patients quite excessive, are…
View more
Author(s):
Somsupha Kanjanauthai
,
Kabir Bhasin
,
Luigi Pirelli
,
et al
Added:
3 years ago
Transcatheter aortic valve replacement (TAVR) has been established as a therapeutic option for patients with severe symptomatic aortic stenosis who are considered to be of intermediate, high or prohibitive surgical risk.1–5 As a result of favorable TAVR outcomes and substantial improvements in transcatheter heart valve (THV) technologies and implantation techniques, the feasibility of broadening…
View more
Added:
3 years ago
Source:
Radcliffe Cardiology
Over the last decade, Transcatheter Aortic Valve Replacement (TAVR) has rapidly grown in popularity across Europe and North America as an alternative for high-risk aortic stenosis patients considered to be inoperable.
But, what are the costs associated with this revolutionary procedure? Are low-risk patients eligible candidates? This, and more, is reviewed in the infographic below. Scroll down…
View more
Author(s):
Eden C Payabyab
,
Lindsay S Elbaum
,
Navneet Sharma
,
et al
Added:
2 years ago
Author(s):
Roberto Spina
,
Chris Anthony
,
David WM Muller
,
et al
Added:
3 years ago
Transcatheter aortic valve replacement (TAVR) with either the balloonexpandable Edwards SAPIEN XT valve (Edwards Lifesciences, Irvine, California), or the self-expandable CoreValve prosthesis (Medtronic, Minneapolis, Minnesota) has become the established therapeutic modality for severe aortic valve stenosis in patients who are not deemed suitable for surgical intervention due to excessively high…
View more
TAVR in Bicuspid Disease
Author(s):
Nicolas M Van Mieghem
,
Basel Ramlawi
,
Didier Tchétché
,
et al
Start date:
Jun 04, 2020
Broadcast
Author(s):
Hemal Gada
,
Kendra J Grubb
Added:
1 year ago
Dr Hemal Gada (UPMC Heart and Vascular Institute, US) and his team published an informative review article on “Transcatheter Aortic Valve Replacement Optimization Strategies: Cusp Overlap, Commissural Alignment, Sizing, and Positioning”, in a comprehensive special focus issue on the “Lifetime Management of Patients With Aortic Stenosis” edited byDr Kendra Grubb(Emory Structural Heart and Valve…
View more
Impact on Implantation Depth
Author(s):
Verena Veulemans
,
Oliver Maier
,
Tobias Zeus
Added:
1 month ago
Article